Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial

Sigismond Lasocki, Xavier Capdevila, Bruno Vielle, Benjamin Bijok, Maria Lahlou-Casulli, Vincent Collange, Nicolas Grillot, Marc Danguy des Déserts, Alexis Duchalais, Bertrand Delannoy, Bertrand Drugeon, Pierre Bouzat, Jean David, Louis Rony, Thibault Loupec, Maxime Léger, Emmanuel Rineau, G Bouhours, Sigismond Lasocki, Adeline Lebail, Maxime Léger, Elsa Parot‐Schinkel, Emmanuel Rineau, Louis Rony, Bruno Vielle, Xavier Capdevilla, Thibault Loupec, Benjamin Mounet, Fabien Swisser, Marc Danguy des Déserts, Raphaël Cinotti, Nicolas Grillot, Karim Asehnoune, Antoine Roquilly, Hélène Beloeil, Maria Lahlou-Casulli, Vincent Collange, Sébastien Parent, Bertrand Delannoy, Olivier Desebbe, Alexis Duchalais, Bertrand Drugeon, Jérémy Guénézan, Pierre Bouzat, Sabine Drevet, G. Gavazzi, Jules Grèze, Benjamin Bijok, Delphine Garrigue, Jean David, Delphine Garrigue, Jean David